XML 22 R9.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES              
Net income $ 11,648 $ (272) $ 11,279 $ 6,768 $ 11,376 $ 18,047  
Adjustments to reconcile net income to net cash provided by operating activities:              
Gain on sales of loans originated for sale         (2,430) (82)  
Earnings on investment in bank-owned life insurance (627)   (493)   (1,207) (970)  
Gain on life insurance proceeds (31)   0   (285) 0  
Gain on sales or calls of securities (22)   0   (22) (69)  
(Gain) loss on equity securities (3)   (1)   (17) 9  
Restricted stock compensation expense         888 775  
Depreciation and amortization         3,218 1,524  
Provision for (reversal of) credit losses and unfunded commitments         4,906 (3,177)  
Net amortization of investment securities premiums         707 868  
Increase in interest receivable         (72) (401)  
(Decrease) increase in interest payable         (911) 758  
Mortgage loans originated for sale         (81,439) (5,026)  
Proceeds from sales of loans originated for sale         80,352 3,587  
(Increase) decrease in other assets         (6,777) 7,650  
Decrease (increase) in deferred tax asset         5,577 (790)  
Increase (decrease) in other liabilities         3,827 (2,179)  
Net Cash Provided by Operating Activities         17,691 20,524  
CASH FLOWS FROM INVESTING ACTIVITIES              
Proceeds from calls/maturities of investment securities held to maturity         335 369  
Proceeds from calls/maturities of investment securities available for sale         25,976 15,875  
Proceeds from sales of investment securities available for sale         98,272 14,336  
Purchase of investment securities available for sale         (76,934) 0  
Redemption (purchase) of restricted investment in bank stocks         643 (2,176)  
Net increase in loans         (10,575) (51,652)  
Net cash and cash equivalents received from acquisition         36,206 0  
Net capital expenditures         (474) (365)  
Net Cash Provided by (Used in) Investing Activities         73,449 (23,613)  
CASH FLOWS FROM FINANCING ACTIVITIES              
Net increase (decrease) in noninterest-bearing deposits         6,426 (20,606)  
Net decrease in interest-bearing deposits         (15,894) (2,619)  
Net increase (decrease) in short-term borrowings         27,215 (7,908)  
Proceeds from long-term borrowings         0 60,000  
Repayments on long-term borrowings         (40,188) 0  
Dividends paid         (6,923) (5,267)  
Common stock repurchased         (5,964) (147)  
Common stock issued, net of restricted stock forfeitures and withheld for taxes         35 (48)  
Net Cash (Used in) Provided by Financing Activities         (35,293) 23,405  
Net Increase in Cash and Cash Equivalents         55,847 20,316  
CASH AND CASH EQUIVALENTS — BEGINNING   $ 47,262   $ 65,958 47,262 65,958 $ 65,958
CASH AND CASH EQUIVALENTS — ENDING $ 103,109   $ 86,274   103,109 86,274 $ 47,262
Supplemental disclosures of cash flow information              
Cash paid for interest         19,262 10,885  
Cash paid for income taxes         1,211 1,500  
Supplemental disclosures of certain noncash activities:              
Recognition of Operating Lease Right of Use Assets, Noncash         729 0  
Recognition of operating lease liabilities, noncash         729 0  
Fair Value of Assets Acquired         877,557 0  
Liabilities Assumed         793,908 0  
Common shares issued         $ 83,649 $ 0